Intelligence Platform
Patents
Browse 991 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8232302
Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
granted patentUS 8232406
c-MET protein kinase inhibitors
granted patentUS 8227615
Pyridyl derivatives as CFTR modulators
granted patentUS 8217048
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted patentUS 8217172
Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-
granted patentUS 8217056
Triazolothiadiazole inhibitor of c-Met protein kinase
granted patentUS 8211935
Heterocyclic derivatives for modulation of calcium channels
granted patentUS 8202889
Inhibitors of bacterial IMPDH
granted patentUS 8202861
Compositions useful as inhibitors of voltage-gated sodium channels
granted patentUS 8193352
Gyrase inhibitors and uses thereof
granted patentUS 8193194
Ion channel modulators and methods of use
granted patentUS 8188071
Amino substituted pyridines as potent kinase inhibitors
granted patentUS 8188283
Modulators of cystic fibrosis transmembrane conductance regulator
granted patentUS 8188281
Azaindoles useful as inhibitors of JAK and other protein kinases
granted patentUS 8188134
Thiophene-carboxamides useful as inhibitors of protein kinases
granted patentUS 8188095
Gyrase inhibitors and uses thereof
granted patentUS 8187874
Drug discovery method
granted patentUS 8173635
Kinase inhibitors
granted patentUS 8168798
Caspase inhibitor prodrugs
granted patentUS 8163720
Pyrrolidinyl phenyl sulphonamides as modulators of ion channels
granted patentUS 8163917
Azaindoles useful as inhibitors of Janus kinases
granted patentUS 8163772
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3
granted patentUS 8163737
CGRP receptor antagonists
granted patentUS 8163732
Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase
granted